ORPHAN MEDICAL INC
SC 13G, 2000-03-24
PHARMACEUTICAL PREPARATIONS
Previous: OAKWOOD MORTGAGE INVESTORS INC, 8-K, 2000-03-24
Next: CG VARIABLE LIFE INSURANCE SEPARATE ACCOUNT I, 24F-2NT, 2000-03-24




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                  SCHEDULE 13G


                    Under the Securities Exchange Act of 1934



                              ORPHAN MEDICAL, INC.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                   687303 10 7
                                 (CUSIP Number)

                                February 22, 2000
             (Date of Event which Requires Filing of this Statement)

         Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

                  |_| Rule 13d-1 (b)
                  |x| Rule 13d-1 (c)
                  |_| Rule 13d-1 (d)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


<PAGE>


CUSIP No. 687303 10 7

(1)      Name of Reporting Person
         S.S. or I.R.S. Identification No. of Above Person
         OrbiMed Advisors Inc.

         ----------------------------------------------------------------------
(2)      Check the Appropriate Box if a Member of Group (See Instructions)

         [  ]      (a)
         [  ]      (b)

         -----------------------------------------------------------------------
(3)      SEC Use Only

         ----------------------------------------------------------------------
(4)      Citizenship or Place of Organization    British Virgin Islands

         ----------------------------------------------------------------------
   Number of      (5)      Sole Voting Power   0
   Shares
   Beneficially   -------------------------------------------------------------
   Owned by       (6)      Shared Voting Power 1,265,000
   Each
   Reporting      -------------------------------------------------------------
   Person         (7)      Sole Dispositive Power     0
   With
                  -------------------------------------------------------------
                  (8)      Shared Dispositive Power  1,265,000

         ----------------------------------------------------------------------
(9)      Aggregate Amount Beneficially Owned by Each Reporting Person
         1,265,000

         ----------------------------------------------------------------------
(10)     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
         Instructions)

         ----------------------------------------------------------------------
(11)     Percent of Class Represented by Amount in Row (9)
         16.1%

         ----------------------------------------------------------------------
(12)     Type of Reporting Person (See Instructions) IA

         ----------------------------------------------------------------------


<PAGE>


CUSIP No. 687303 10 7

(1)      Name of Reporting Person
         S.S. or I.R.S. Identification No. of Above Person
         OrbiMed Advisors LLC

         ----------------------------------------------------------------------
(2)      Check the Appropriate Box if a Member of Group (See Instructions)

         [  ]      (a)
         [  ]      (b)

         ----------------------------------------------------------------------
(3)      SEC Use Only

         ----------------------------------------------------------------------
(4)      Citizenship or Place of Organization        Delaware

         ----------------------------------------------------------------------
   Number of      (5)      Sole Voting Power   0
   Shares
   Beneficially   -------------------------------------------------------------
   Owned by       (6)      Shared Voting Power 1,265,000
   Each
   Reporting      -------------------------------------------------------------
   Person         (7)      Sole Dispositive Power     0
   With
                  -------------------------------------------------------------
                  (8)      Shared Dispositive Power  1,265,000

         ----------------------------------------------------------------------
(9)      Aggregate Amount Beneficially Owned by Each Reporting Person
         1,265,000

         ----------------------------------------------------------------------
(10)     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
         Instructions)

         ----------------------------------------------------------------------
(11)     Percent of Class Represented by Amount in Row (9)
         16.1%

         ----------------------------------------------------------------------
(12)     Type of Reporting Person (See Instructions) CO

         ----------------------------------------------------------------------


<PAGE>


CUSIP No. 687303 10 7

(1)      Name of Reporting Person
         S.S. or I.R.S. Identification No. of Above Person
         Caduceus Capital Trust

         ----------------------------------------------------------------------
(2)      Check the Appropriate Box if a Member of Group (See Instructions)

         [  ]      (a)
         [  ]      (b)

         ----------------------------------------------------------------------
(3)      SEC Use Only

         ----------------------------------------------------------------------
(4)      Citizenship or Place of Organization        Bermuda

         ----------------------------------------------------------------------
   Number of      (5)      Sole Voting Power   0
   Shares
   Beneficially   -------------------------------------------------------------
   Owned by       (6)      Shared Voting Power 1,265,000
   Each
   Reporting      -------------------------------------------------------------
   Person         (7)      Sole Dispositive Power     0
   With
                  -------------------------------------------------------------
                  (8)      Shared Dispositive Power  1,265,000

         ----------------------------------------------------------------------
(9)      Aggregate Amount Beneficially Owned by Each Reporting Person
         1,265,000


         ----------------------------------------------------------------------
(10)     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
         Instructions)

         ----------------------------------------------------------------------
(11)     Percent of Class Represented by Amount in Row (9)
         16.1%

         ----------------------------------------------------------------------
(12)     Type of Reporting Person (See Instructions) OO

         ----------------------------------------------------------------------


<PAGE>


CUSIP No. 687303 10 7

(1)      Name of Reporting Person
         S.S. or I.R.S. Identification No. of Above Person
         Caduceus Capital II, L.P.

         ----------------------------------------------------------------------
(2)      Check the Appropriate Box if a Member of Group (See Instructions)

         [  ]      (a)
         [  ]      (b)

         ----------------------------------------------------------------------
(3)      SEC Use Only

         ----------------------------------------------------------------------
(4)      Citizenship or Place of Organization        Delaware

         ----------------------------------------------------------------------
   Number of      (5)      Sole Voting Power   0
   Shares
   Beneficially   -------------------------------------------------------------
   Owned by       (6)      Shared Voting Power 1,265,000
   Each
   Reporting      -------------------------------------------------------------
   Person         (7)      Sole Dispositive Power     0
   With
                  -------------------------------------------------------------
                  (8)      Shared Dispositive Power  1,265,000

         ----------------------------------------------------------------------
(9)      Aggregate Amount Beneficially Owned by Each Reporting Person
         1,265,000

         ----------------------------------------------------------------------
(10)     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
         Instructions)

         ----------------------------------------------------------------------
(11)     Percent of Class Represented by Amount in Row (9)
         16.1%

         ----------------------------------------------------------------------
(12)     Type of Reporting Person (See Instructions) PN

         ----------------------------------------------------------------------


<PAGE>


CUSIP No. 687303 10 7

(1)      Name of Reporting Person
         S.S. or I.R.S. Identification No. of Above Person
         PaineWebber Eucalyptus Fund, LLC

         ----------------------------------------------------------------------
(2)      Check the Appropriate Box if a Member of Group (See Instructions)

         [  ]      (a)
         [  ]      (b)

         ----------------------------------------------------------------------
(3)      SEC Use Only

         ----------------------------------------------------------------------
(4)      Citizenship or Place of Organization        Delaware

         ----------------------------------------------------------------------
   Number of      (5)      Sole Voting Power   0
   Shares
   Beneficially   -------------------------------------------------------------
   Owned by       (6)      Shared Voting Power 1,265,000
   Each
   Reporting      -------------------------------------------------------------
   Person         (7)      Sole Dispositive Power     0
   With
                  -------------------------------------------------------------
                  (8)      Shared Dispositive Power  1,265,000

         ----------------------------------------------------------------------
(9)      Aggregate Amount Beneficially Owned by Each Reporting Person
         1,265,000

         ----------------------------------------------------------------------
(10)     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
         Instructions)

         ----------------------------------------------------------------------
(11)     Percent of Class Represented by Amount in Row (9)
         16.1%

         ----------------------------------------------------------------------
(12)     Type of Reporting Person (See Instructions) CO

         ----------------------------------------------------------------------


<PAGE>


CUSIP No. 687303 10 7

(1)      Name of Reporting Person
         S.S. or I.R.S. Identification No. of Above Person
         PaineWebber Eucalyptus Fund, Ltd.

         ----------------------------------------------------------------------
(2)      Check the Appropriate Box if a Member of Group (See Instructions)

         [  ]      (a)
         [  ]      (b)

         ----------------------------------------------------------------------
(3)      SEC Use Only

         ----------------------------------------------------------------------
(4)      Citizenship or Place of Organization        Cayman Islands

         ----------------------------------------------------------------------
   Number of      (5)      Sole Voting Power   0
   Shares
   Beneficially   -------------------------------------------------------------
   Owned by       (6)      Shared Voting Power 1,265,000
   Each
   Reporting      -------------------------------------------------------------
   Person         (7)      Sole Dispositive Power     0
   With
                  -------------------------------------------------------------
                  (8)      Shared Dispositive Power  1,265,000

         ----------------------------------------------------------------------
(9)      Aggregate Amount Beneficially Owned by Each Reporting Person
         1,265,000

         ----------------------------------------------------------------------
(10)     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
         Instructions)

         ----------------------------------------------------------------------
(11)     Percent of Class Represented by Amount in Row (9)
         16.1%

         ----------------------------------------------------------------------
(12)     Type of Reporting Person (See Instructions) CO

         ----------------------------------------------------------------------


<PAGE>


Item 1.           Issuer

                           (a)      Orphan Medical, Inc.
                           (b)      13911 Ridgedale Drive, Minnetanka, MN 55305

Item 2.           Persons Filing

                           (a)      Name of Persons Filing:

                                    OrbiMed Advisors Inc.
                                    OrbiMed Advisors LLC
                                    Caduceus Capital Trust
                                    Caduceus Capital II, L.P.
                                    PaineWebber Eucalyptus Fund, LLC
                                    PaineWebber Eucalyptus Fund, Ltd.

                           (b)      Address of Principal Offices:
                                    c/o OrbiMed Advisors LLC
                                    767 Third Avenue, 6th Floor
                                    New York, New York  10010

                           (c)      Citizenship:

                                    Please refer to Item 4 on each cover sheet
                                    for each filing person

                           (d)      Title of Class of Securities:

                                    Common Stock

                           (e)      CUSIP Number: 687303 10 7

Item 3.           Not Applicable

Item 4.           Ownership

                  Please see Items 5, 6, 7, 8, 9, and 11 for each cover sheet
                  for each filing entity.

Item 5.           Ownership of Five Percent or Less of a Class

                  Not applicable.

Item 6.           Ownership of More than Five Percent on Behalf of Another
                  Person

                  Not applicable.

Item 7.           Identification and Classification of the Subsidiary Which
                  Acquired the Security Being Reported on by the Parent Holding
                  Company

                  Not applicable.


<PAGE>


Item 8.           Identification and Classification of Members of the Group

                  Not Applicable.

Item 9.           Notice of Dissolution of Group

                  Not Applicable.

Item 10.          Certification

                  By signing below I certify that, to the best of my knowledge
                  and belief, the securities referred to above were not acquired
                  and are not held for the purpose of or with the effect of
                  changing or influencing the control of the issuer of the
                  securities and were not acquired and are not held in
                  connection with or as a participant in any transaction having
                  that purpose or effect.


<PAGE>


                                    SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date: March 21, 2000

                                    ORBIMED ADVISORS INC.

                                             By: /s/ Samuel D. Isaly
                                                 -------------------------------
                                                 Name: Samuel D. Isaly
                                                 Title: President


                                    ORBIMED ADVISORS LLC

                                             By: /s/ Samuel D. Isaly
                                                 -------------------------------
                                                 Name: Samuel D. Isaly
                                                 Title: Managing Member


                                    CADUCEUS CAPITAL TRUST

                                             By: /s/ Deborah O'Donnel
                                                 -------------------------------
                                                 Name: Deborah O'Donnel
                                                 Title: Secretary


                                    CADUCEUS CAPITAL II, L.P.

                                    By:      OrbiMed Advisors LLC,
                                             its general partner

                                             By: /s/  Samuel D. Isaly
                                                 -------------------------------
                                                 Name: Samuel D. Isaly
                                                 Title: Managing Member


                                    PAINEWEBBER EUCALYPTUS FUND, LLC

                                             By: /s/ Samuel D. Isaly
                                                 -------------------------------
                                                 Name: Samuel D. Isaly
                                                 Title: Director


<PAGE>


                                    PAINEWEBBER EUCALYPTUS FUND, LTD.

                                             By: /s/ Samuel D. Isaly
                                                 -------------------------------
                                                 Name: Samuel D. Isaly
                                                 Title: Director



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission